“I’m a big advocate for making scientific data as available as possible to as many people as possible,” says Ben Orsburn. A self-described mass spectrometry enthusiast, Orsburn has been quietly progressing the analytical field for the last 12 years during posts at renowned organizations such as Thermo Fisher Scientific and the National Cancer Institute. But for as long as he’s been avid for analytics, Orsburn’s greatest aim has always been to help create a world-first genetics sequence. And now, as the co-creator of the first cannabis proteome, he can finally celebrate.
“It was very surprising to me, looking at this industry, that the proteomes of these plants have never been done,” he tells Analytical Cannabis.
For those uninitiated with genetics, proteomes are a bit like the total product of every active gene in an organism. For example, while the DNA of a frog remains fundamentally the same throughout its lifecycle, its proteome changes as its genes are turned on and off to produce the different proteins which transition it from tadpole to adult. And a map of all these potential proteins – the proteome – could be a lucrative tool for anyone thinking of profiting from an organism.
Read more at analyticalcannabis.com